CDT — Conduit Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $6.09m
- $12.76m
Annual balance sheet for Conduit Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | — | — | 4.23 | 0.554 |
| Net Total Receivables | — | — | — | 0.489 |
| Prepaid Expenses | ||||
| Total Current Assets | — | — | 5.73 | 2.71 |
| Net Property, Plant And Equipment | — | — | — | 0.303 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 0 | 0.005 | 7.22 | 4.19 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 2.23 | 3.99 | 1.8 | 10.7 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 5.94 | 10.1 | 7.68 | 11 |
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -5.94 | -10.1 | -0.457 | -6.79 |
| Total Liabilities & Shareholders' Equity | 0 | 0.005 | 7.22 | 4.19 |
| Total Common Shares Outstanding |